These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1049 related articles for article (PubMed ID: 19106348)

  • 1. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
    Rybak M; Lomaestro B; Rotschafer JC; Moellering R; Craig W; Billeter M; Dalovisio JR; Levine DP
    Am J Health Syst Pharm; 2009 Jan; 66(1):82-98. PubMed ID: 19106348
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
    Clin Infect Dis; 2009 Aug; 49(3):325-7. PubMed ID: 19569969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Am J Health Syst Pharm; 2020 May; 77(11):835-864. PubMed ID: 32191793
    [No Abstract]   [Full Text] [Related]  

  • 4. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
    Pharmacotherapy; 2009 Nov; 29(11):1275-9. PubMed ID: 19873687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro B
    Clin Infect Dis; 2020 Sep; 71(6):1361-1364. PubMed ID: 32658968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise T; Levine D; Bradley J; Liu C; Mueller B; Pai M; Wong-Beringer A; Rotschafer JC; Rodvold K; Maples HD; Lomaestro BM
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):281-284. PubMed ID: 32659787
    [No Abstract]   [Full Text] [Related]  

  • 8. [Streptogramins and glycopeptides].
    Tsuji A
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():360-6. PubMed ID: 17455646
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis.
    Steinmetz T; Eliakim-Raz N; Goldberg E; Leibovici L; Yahav D
    Clin Microbiol Infect; 2015 Jul; 21(7):665-73. PubMed ID: 25887712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New target concentrations for vancomycin in Hong Kong.
    You JH; Chow SS; Lui JW; Ip M
    Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.
    Chua K; Howden BP
    Curr Opin Infect Dis; 2009 Dec; 22(6):525-34. PubMed ID: 19738465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
    Patel K; Crumby AS; Maples HD
    Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin.
    Murphy M; Girdwood ST; Scheetz MH
    J Hosp Med; 2020 Dec; 15(12):740-742. PubMed ID: 33231544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
    Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
    J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.
    Lee P; DiPersio D; Jerome RN; Wheeler AP
    J Med Libr Assoc; 2007 Oct; 95(4):374-80. PubMed ID: 17971884
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing the Clinical Use of Vancomycin.
    Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
    Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of hemodialysis clearance parameter for vancomycin therapeutic drug monitoring during continuous hemodiafiltration in an infant.
    Shiohira H; Isagawa S; Yamada S; Sunagawa S; Nakamatsu M; Yonaha F; Hokama N; Fujita J; Nakamura K
    Pharmazie; 2018 Dec; 73(12):737-739. PubMed ID: 30522560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protocol for developing a clinical practice guideline for therapeutic drug monitoring of vancomycin.
    Ye ZK; Chen K; Chen YL; Zhai SD
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):469-472. PubMed ID: 27376822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.
    Lee JY; Howden BP
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):855-69. PubMed ID: 25947636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
    Hazlewood KA; Brouse SD; Pitcher WD; Hall RG
    Am J Med; 2010 Feb; 123(2):182.e1-7. PubMed ID: 20103028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.